Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma
Teclistamab in combination with subcutaneous daratumumab and lenalidomide shows promising results in patients with multiple myeloma
Treatment decision guided by CTC count may improve long-term outcomes for mBC
The future of precision oncology
The concept of pan-tumour therapeutics
Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma
Cervical cancer prevention and care indicators for women living with HIV in Sub-Saharan Africa: Delphi Method
EPIC study: Pre-existing cardiometabolic diseases impact cancer stage
Individualised breast cancer risk assessment model for BreastScreen Norway
IGHER provides support for African healthcare research, clinical trials and personalised medicine
Genomic testing in biliary tract cancers
Molecular profiling in prostate cancer: key challenges for clinical implementation
Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems